Sinotherapeutics Inc. A Financial Flexibility Index
Sinotherapeutics Inc. A financial flexibility index. Sinotherapeutics Inc. A (688247) has a Financial Flexibility Index of 0.94x as of December 2025. Free cash flow of CN¥136.88 Million (operating CF CN¥95.33 Million minus capex CN¥41.56 Million) represents 1% of total liabilities (CN¥146.12 Million). See Sinotherapeutics Inc. A free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sinotherapeutics Inc. A (2020–2025)
Financial flexibility index of Sinotherapeutics Inc. A from 2020 to 2025. Historical Financial Flexibility Index trend for Sinotherapeutics Inc. A across 6 annual periods. Check earnings quality score of Sinotherapeutics Inc. A to evaluate the quality of earnings relative to operating cash generation.
Sinotherapeutics Inc. A Financial Flexibility Index by Year (2020–2025)
Sinotherapeutics Inc. A financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Sinotherapeutics Inc. A. For the full cash flow conversion analysis, see Sinotherapeutics Inc. A cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.94x | CN¥136.88 Million | CN¥95.33 Million | CN¥146.12 Million | ▼ -25.0% |
| 2024 | 1.25x | CN¥225.16 Million | CN¥130.23 Million | CN¥180.30 Million | ▲ +264.1% |
| 2023 | 0.34x | CN¥51.91 Million | CN¥12.96 Million | CN¥151.36 Million | ▼ -78.7% |
| 2022 | 1.61x | CN¥249.52 Million | CN¥73.18 Million | CN¥155.05 Million | ▲ +59.8% |
| 2021 | 1.01x | CN¥161.78 Million | CN¥145.77 Million | CN¥160.62 Million | ▼ -26.7% |
| 2020 | 1.37x | CN¥248.38 Million | CN¥210.04 Million | CN¥180.76 Million | — |